Mounjaro allergic reaction and rash: what the signs mean

Injection-site redness, itching or a small lump at the injection spot are common and usually settle within a day or two — rotating sites helps reduce them.
Widespread rash, hives, facial swelling, or difficulty breathing are potential signs of a serious allergic reaction and require emergency medical help immediately.
Suspected side effects from Mounjaro can be reported directly to the MHRA at yellowcard.mhra.gov.uk, reports from patients and carers are encouraged.
A prescriber, not a web search, should advise on whether to continue, pause or stop treatment if you develop any unexpected skin reaction.

A rash or skin change after starting Mounjaro can feel alarming, especially when you're not sure whether it's a minor irritation or something that needs urgent attention. Most skin reactions on tirzepatide are mild and localise around the injection site, but a small number of people develop signs of a broader allergic reaction that warrants prompt medical assessment. These are prescription-only medicines — any side effect worth worrying about is one your prescriber should know about.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to read a skin reaction on Mounjaro, and when to act fast

You've noticed something on your skin after an injection, here's how to think about it

You've just done your weekly Mounjaro injection and, a short while later, there's redness where the pen went in. Maybe some itching. Possibly a small raised patch. The first thing worth knowing is that localised injection-site reactions are among the most frequently reported skin responses to tirzepatide, and the NHS medicines page for tirzepatide lists injection-site redness, pain and swelling as common effects. They typically fade within 24 to 48 hours.

Rotating your injection site between the abdomen, outer thigh and upper arm with each pen is the simplest way to reduce the likelihood of these local reactions recurring. Injecting into tissue that is still recovering from last week tends to make things worse. Letting the pen reach room temperature before injecting, and injecting slowly, can also reduce discomfort.

If the redness at the site spreads noticeably, becomes hot to the touch, or develops into a firm lump that doesn't resolve after several days, it is worth contacting your prescriber. That kind of prolonged reaction may need a review of your injection technique or site choices. Our overview of Mounjaro side effects covers the full range of what people commonly report.

One thing patients tell us they wish they'd known earlier: a reaction that starts small but doesn't follow the usual 48-hour settling pattern deserves a call, not just monitoring.

When a rash might mean a true allergic reaction to tirzepatide

A genuine allergic reaction to tirzepatide itself is less common than a local injection-site irritation, but it does occur. The pattern to look for is a reaction that spreads beyond the injection site, a generalised rash, hives (raised, itchy welts across the body), or swelling that appears in the face, lips, tongue or throat. These suggest your immune system is responding to the medicine, not just the needle.

There is an important distinction between two kinds of allergic response. A mild allergic reaction (for example, a patchy rash or diffuse itching that appears within hours of the injection) needs medical attention that day, but is not immediately life-threatening. A severe allergic reaction, called anaphylaxis, is a medical emergency. Signs include a rapidly spreading rash combined with any of the following: difficulty breathing or swallowing, tightness in the chest, dizziness, rapid heart rate, or feeling faint. Call 999 without delay if those symptoms appear together.

The Mounjaro SmPC on the eMC lists hypersensitivity reactions, including anaphylaxis, as known but rare adverse events. Rare does not mean impossible, and understanding the difference between a nuisance reaction and an emergency is exactly why this information matters. If you are uncertain whether what you're experiencing falls into the mild or serious category, err on the side of seeking assessment. A pharmacist or 111 can help you triage if you're unsure.

For a broader look at what distinguishes a transient sensitivity from a true allergy, our page on whether you can be allergic to Mounjaro goes into the mechanism in more detail.

When to get medical help, and how urgent is urgent

This section exists because the line between "watch and wait" and "go now" is not always obvious from a rash alone. Here is a practical guide.

Call 999 or go to A&E immediately if you have a rash alongside difficulty breathing, throat tightening, facial or tongue swelling, faintness, or collapse. This is anaphylaxis and it cannot wait.

Contact a GP, 111 or your prescriber the same day if you have a rash spreading beyond the injection site, widespread hives, or swelling that is not in your airway but is spreading to your face or limbs, and our guidance on how to recognise and respond to a reaction to Mounjaro can help you describe what you're seeing when you make that call. These warrant prompt clinical review even if breathing is unaffected.

Speak to your prescriber at your next opportunity if you have a localised reaction at the injection site that is more intense than usual, slower to settle, or happening repeatedly in different sites. They may recommend an antihistamine, a technique adjustment, or a review of whether to continue at the same dose.

Whatever the severity, patients experiencing suspected side effects are encouraged to report them to the MHRA's Yellow Card scheme. Reports from patients directly contribute to the ongoing safety monitoring of tirzepatide, which carries the Black Triangle (▼) designation indicating it is subject to additional surveillance. You do not need to be certain the reaction was caused by the medicine to report it.

Our detailed page on allergic reactions to Mounjaro covers the clinical context further, including what a prescriber is likely to ask you.

After a reaction: what happens next with your treatment

A skin reaction does not automatically mean you have to stop Mounjaro permanently. The next step depends entirely on the nature of the reaction, and that is a decision for your prescriber, not one to make alone based on what you read online.

For mild, localised reactions that settle quickly, many people continue treatment with adjustments to site rotation or injection technique. For a broader but non-severe reaction, a prescriber may recommend a period without the medicine while the reaction resolves, then reassess. For confirmed anaphylaxis or a severe hypersensitivity, continuing tirzepatide is not appropriate and your prescriber will discuss alternatives with you.

If you are currently on Mounjaro through a service and have experienced a reaction, the practical first step is to contact that service's aftercare team, and our page covering what to do if you've had a bad reaction to Mounjaro sets out the steps to take before you make that call. At nume, our prescribers are available seven days a week. You can reach us through our contact page, describe what you've noticed and when, and a prescriber will advise on what to do next.

People considering starting treatment often ask about reactions like this before they begin, and our page on what it means to be allergic to Mounjaro is a useful starting point if you have a history of medicine sensitivities and want to understand your risk before your consultation. Our clinical team, led by a GPhC-registered prescriber, discusses known side effects including the possibility of skin reactions as part of every consultation, so if you have pre-existing skin sensitivities or a history of allergic reactions to medicines, that is exactly the kind of thing to raise before treatment starts. You can begin that conversation through our free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions